Six Indiana University Bloomington researchers have received grants from a program that supports developing translational research projects; offered by the Johnson Center for Innovation and Translational Research. Dr. Hui-Chen Lu received $25,000 to develop “Preclinical studies to evaluate RNA-based therapeutic agents for reducing neurodegeneration,". The goal of the project is to identify biomarkers that assess the efficacy of agents in modulating neuroinflammatory responses. These agents could slow down neurodegenerative conditions like Alzheimer's disease.